Sort
25,944 grants matching “neurodegeneration”
Immunogenetic Determinants of Disease Risk in Neurological Disease
$1,371,787Jorge R. Oksenberg · University Of California, San Francisco · U19 · FY2018 · NS
Immunogenetic Determinants of Disease Risk in Neurological Disease
$1,371,719Jorge R. Oksenberg · University Of California, San Francisco · U19 · FY2017 · NS
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease
$1,371,564Eva L Feldman · University Of Michigan At Ann Arbor · U01 · FY2020 · AG
Resource for Quantitative Functional MRI
$1,371,516Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2012 · EB
NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE
$1,370,407Nathan S. Kline Institute For Psych Res · P01 · FY2000 · AG
Novel Histone Deacetylase Inhibitors as Therapeutics for Huntington's Disease
$1,370,391Joel M. Gottesfeld · Scripps Research Institute, The · U01 · FY2010 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,368,800Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2019 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,368,800Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2018 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,368,800Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2017 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,368,800Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2020 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,368,800Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2016 · NS
Center for Gene Environment in Parkinson's Disease
$1,368,616Marie-Francoise S Chesselet · University Of California Los Angeles · P01 · FY2012 · ES
Leveraging Longitudinal Data and Informatics Technology to Understand the Role of Bilingualism in Cognitive Resilience, Aging and Dementia
$1,367,793Li Zhou · Brigham And Women'S Hospital · R01 · FY2024 · AG
Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease
$1,366,586David Radin · Biostrategies, Lc · R44 · FY2017 · NS
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging
$1,364,712Julie A Schneider · Rush University Medical Center · R01 · FY2023 · AG
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging
$1,364,712Julie A Schneider · Rush University Medical Center · R01 · FY2024 · AG
NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE
$1,363,573Nathan S. Kline Institute For Psych Res · P01 · FY2001 · AG
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection
$1,361,420Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2025 · AG
TRANSCRIPTIONAL RESPONSES TO MITOCHONDRIAL DYSFUNCTION
$1,360,888Rajiv R Ratan · Winifred Masterson Burke Med Res Inst · P01 · FY2008 · AG
MITOCHONDRIAL DYSFUNCTION IN NEUROGEGENERATION OF AGING
$1,360,888Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2008 · AG
Staging Alzheimer disease with blood-based biomarkers
$1,360,491Suzanne Elizabeth Schindler · Washington University · R01 · FY2021 · AG
Longitudinal Imaging Biomarkers of Disease Progression in DLB
$1,359,564Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2021 · NS
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$1,358,887John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Multimodal Investigation of Cellular Adaptation Across Timescales
$1,358,408David Pincus · University Of Chicago · RM1 · FY2025 · GM
EXCITATORY TRANSMITTERS, MEMORY, AGING AND DEMENTIA
$1,357,987Washington University · P01 · FY2002 · AG